LeonaBio, Inc. (LONA)
6.14
+0.39
(+6.78%)
USD |
NASDAQ |
Oct 12, 16:00
6.14
0.00 (0.00%)
After-Hours: 19:33
LeonaBio Price : 6.14 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 5.82 | 6.10 | 5.56 | 5.75 | 66684.00 |
| Oct 08, 2026 | 5.78 | 6.070 | 5.515 | 5.75 | 134603.0 |
| Oct 07, 2026 | 5.77 | 6.21 | 5.61 | 5.83 | 178059.0 |
| Oct 06, 2026 | 5.63 | 5.88 | 5.25 | 5.75 | 175828.0 |
| Oct 05, 2026 | 4.75 | 5.72 | 4.51 | 5.58 | 296080.0 |
| Oct 02, 2026 | 4.44 | 4.90 | 4.18 | 4.82 | 332594.0 |
| Oct 01, 2026 | 3.515 | 5.340 | 3.42 | 4.38 | 6.300M |
| Sep 30, 2026 | 3.51 | 3.59 | 3.31 | 3.57 | 40258.00 |
| Sep 29, 2026 | 2.80 | 3.750 | 2.570 | 3.51 | 439131.0 |
| Sep 28, 2026 | 3.30 | 3.30 | 2.21 | 2.87 | 949118.0 |
| Sep 25, 2026 | 5.19 | 5.595 | 3.12 | 3.25 | 349444.0 |
| Sep 24, 2026 | 6.040 | 6.315 | 4.90 | 4.99 | 150996.0 |
| Sep 23, 2026 | 6.35 | 6.35 | 5.69 | 5.89 | 21397.00 |
| Sep 22, 2026 | 6.40 | 6.75 | 5.95 | 6.05 | 34850.00 |
| Sep 21, 2026 | 6.715 | 6.76 | 6.23 | 6.33 | 45593.00 |
| Sep 18, 2026 | 7.59 | 7.655 | 6.61 | 6.79 | 52315.00 |
| Sep 17, 2026 | 6.86 | 6.95 | 6.725 | 6.95 | 5514.00 |
| Sep 16, 2026 | 7.10 | 7.30 | 6.696 | 6.79 | 51345.00 |
| Sep 15, 2026 | 6.90 | 7.47 | 6.90 | 7.24 | 23408.00 |
| Sep 14, 2026 | 7.02 | 7.80 | 7.02 | 7.47 | 23326.00 |
| Sep 11, 2026 | 6.75 | 7.64 | 6.75 | 6.92 | 42677.00 |
| Sep 10, 2026 | 7.14 | 7.705 | 6.81 | 6.86 | 42259.00 |
| Sep 09, 2026 | 7.90 | 8.195 | 7.04 | 7.04 | 78851.00 |
| Sep 08, 2026 | 7.56 | 8.27 | 7.43 | 8.02 | 259358.0 |
| Sep 04, 2026 | 7.924 | 7.924 | 7.439 | 7.56 | 14232.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.06 |
| CNBX Pharmaceuticals, Inc. | 0.0002 |
| Arvinas, Inc. | 7.45 |
| Fulcrum Therapeutics, Inc. | 3.755 |
| Definium Therapeutics, Inc. | 35.19 |
Price Related Metrics
| PEG Ratio | -0.0011 |
| Price to Book Value | 1.722 |
| Earnings Yield | -376.4% |
| Market Cap | 57.85M |
| PEGY Ratio | -0.0011 |